The Women’s Health Profile
Additional Resources:
Understanding your health is necessary for optimal living. As with most other disease states, preventative care and the ability to predict what we are at risk for at the earliest stages is ideal in treating each individual. The Women’s Health Profile can help assess those risk factors associated with genetics, biochemical imbalances, and environmental influences for women of all ages.
A Profile for Female Patients Concerned About:
- Fatigue
- Depression
- Insomnia
- Breast Cancer
- Maintaining Youth
- Reproductive Health
- Cardiovascular Health
- Mental and Neurological Health
- General Health and Nutrition
A Combination of Tests for Women
- Metabolic Syndrome: Tests markers related to central obesity, raised blood pressure, dyslipidemia, insulin resistance, and ADMA.
- ADMA (asymmetric dimethylarginine): Regulates rates of nitric oxide (NO) formation. Nitric oxide acts as a signal molecule in the nervous system, as a weapon against infections, as a regulator of blood pressure, and as a gate keeper of blood flow to the organs.
- Serum Lipid Peroxides: A cardiovascular marker that monitors the tissue damaging effects of oxidative stress.
- Organix: Establish a nutritional and metabolic basis for supplementation.
- Estronex: Measures 2-OHE1 (“good” estrogen) and 16-alpha-OHE1 (“bad” estrogen). Lowering this ratio reduces the risk of estrogen-sensitive cancers, including breast cancer.
- Fatty Acids: Measures omega-3 and omega-6 fatty acids and calculates key indicators, such as AA/EPA ratio, to establish your optimal balance.
The Path to Optimal Health, Ideal Living, and Maintaining Youth
- Endocrine and Insulin Sensitivity
- Estrogen Metabolites
- Cell Regulation: Nitric Oxide Regulation and Eicosanoid Balance
- Cell Protection: Cell Membrane Oxidation and Elemental Cofactor Status
- Metabolic and Nutrient Markers: BVitamin Insufficiency, Cellular Energy, Neural Function, and Detoxification
Clinician information and more details are available on Metametrix’s Website.
